688505 复旦张江
已收盘 11-22 15:00:01
资讯
新帖
简况
复旦张江(01349)下跌5.3%,报2.5元/股
金融界 · 11-22 14:52
复旦张江(01349)下跌5.3%,报2.5元/股
南向资金11月21日净卖出复旦张江5.10万股 连续3日减持
市场透视 · 11-22 09:30
南向资金11月21日净卖出复旦张江5.10万股 连续3日减持
复旦张江(688505)11月15日主力资金净卖出1350.29万元
证券之星 · 11-16
复旦张江(688505)11月15日主力资金净卖出1350.29万元
复旦张江11月15日主力资金流出1338万元 连续3日减仓
市场透视 · 11-15
复旦张江11月15日主力资金流出1338万元 连续3日减仓
复旦张江(01349):股东杨宗孟拟减持公司股份不超过1036.57万股
智通财经 · 11-14
复旦张江(01349):股东杨宗孟拟减持公司股份不超过1036.57万股
复旦张江(688505.SH):两位主要股东拟减持不超1.6%公司股份
智通财经 · 11-14
复旦张江(688505.SH):两位主要股东拟减持不超1.6%公司股份
复旦张江:股东拟减持不超1.6%股份
美港电讯 · 11-14
复旦张江:股东拟减持不超1.6%股份
复旦张江(01349)下跌5.21%,报2.73元/股
金融界 · 11-14
复旦张江(01349)下跌5.21%,报2.73元/股
南向资金11月12日净卖出复旦张江165.60万股 连续3日减持
市场透视 · 11-13
南向资金11月12日净卖出复旦张江165.60万股 连续3日减持
复旦张江11月08日主力资金流出344万元 连续3日减仓
市场透视 · 11-08
复旦张江11月08日主力资金流出344万元 连续3日减仓
复旦张江(01349)上涨5.02%,报2.93元/股
金融界 · 11-07
复旦张江(01349)上涨5.02%,报2.93元/股
复旦张江11月07日遭主力抛售306万元 环比增加4271.43%
市场透视 · 11-07
复旦张江11月07日遭主力抛售306万元 环比增加4271.43%
【港股通】复旦张江(01349)奥贝胆酸片上市申请获得药监局受理 拟用于原发性胆汁性胆管炎
金吾财讯 · 10-31
【港股通】复旦张江(01349)奥贝胆酸片上市申请获得药监局受理 拟用于原发性胆汁性胆管炎
复旦张江(01349):奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书
智通财经 · 10-31
复旦张江(01349):奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书
复旦张江(01349.HK)奥贝胆酸片治疗胆管炎获受理药物上市申请
阿斯达克财经 · 10-31
复旦张江(01349.HK)奥贝胆酸片治疗胆管炎获受理药物上市申请
复旦张江(688505.SH):奥贝胆酸片药品上市申请获得受理
智通财经 · 10-31
复旦张江(688505.SH):奥贝胆酸片药品上市申请获得受理
复旦张江10月31日遭主力抛售514万元 环比增加252.05%
市场透视 · 10-31
复旦张江10月31日遭主力抛售514万元 环比增加252.05%
复旦张江10月29日主力资金流出1150万元 连续3日减仓
市场透视 · 10-29
复旦张江10月29日主力资金流出1150万元 连续3日减仓
复旦张江(01349)下跌5.02%,报2.84元/股
金融界 · 10-29
复旦张江(01349)下跌5.02%,报2.84元/股
公司概况
公司名称:
上海复旦张江生物医药股份有限公司
所属行业:
医药制造业
上市日期:
2020-06-19
主营业务:
上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究开发、生产制造和市场营销。主要产品为盐酸氨酮戊酸外用散、注射用海姆泊芬、抗肿瘤药物长循环盐酸多柔比星脂质体注射液等。其业务主要包括在中国从事研究、开发及销售自行开发的生物医药知识、为客户提供合约制研究、制造及出售医疗产品,以及提供其他医疗服务。公司还通过其子公司从事医疗投资管理、健康产业管理、项目投资、资产管理、投资咨询、商务咨询、医疗咨询及企业战略咨询业务。
发行价格:
8.95
{"stockData":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":8.23,"timestamp":1732258801000,"preClose":8.58,"halted":0,"volume":4477452,"delay":0,"floatShares":711000000,"shares":1036999999,"eps":0.1015,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.35,"latestTime":"11-22 15:00:01","open":8.56,"high":8.57,"low":8.23,"amount":37584300,"amplitude":0.0396,"askPrice":8.25,"askSize":644,"bidPrice":8.23,"bidSize":244,"shortable":0,"etf":0,"ttmEps":0.1015,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":8.58,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":9.44,"lowLimit":7.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1036572100,"pbRate":3.63,"roa":"--","roe":"3.66%","epsLYR":0.11,"committee":-0.099954,"marketValue":8531000000,"floatMarketCap":5848000000,"peRate":81.083746,"changeRate":-0.0408,"turnoverRate":0.0063,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-11-25。","afterMarket":{"amount":0,"volume":0,"close":8.23,"buyVolume":2000,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":8.58}},"requestUrl":"/m/hq/s/688505/wiki","defaultTab":"wiki","newsList":[{"id":"2485289630","title":"复旦张江(01349)下跌5.3%,报2.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485289630","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485289630?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:52","pubTimestamp":1732258366,"startTime":"0","endTime":"0","summary":"11月22日,复旦张江(01349)盘中下跌5.3%,截至14:52,报2.5元/股,成交914.61万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。截至2024年三季报,复旦张江营业总收入5.49亿元、净利润8646.86万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/22145245570409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK0239","688505","01349"],"gpt_icon":0},{"id":"2485047452","title":"南向资金11月21日净卖出复旦张江5.10万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2485047452","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485047452?lang=zh_cn&edition=full","pubTime":"2024-11-22 09:30","pubTimestamp":1732239011,"startTime":"0","endTime":"0","summary":"11月21日,南向资金减持复旦张江5.10万股连续3日减持。截止当日收盘,港股通共持有复旦张江10233.51万股,占流通股31.38%。港股通减持金额前五个股分别为招商银行、中国人民保险集团、比亚迪股份、中国神华、中国海外发展。复旦张江近5个交易日下跌4.35%,港股通累计减持15.20万股;近20个交易日下跌9.59%,港股通累计减持829.60万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122093117abd6068c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122093117abd6068c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239","01349"],"gpt_icon":0},{"id":"2483553698","title":"复旦张江(688505)11月15日主力资金净卖出1350.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483553698","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483553698?lang=zh_cn&edition=full","pubTime":"2024-11-16 08:26","pubTimestamp":1731716780,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月15日收盘,复旦张江报收于8.51元,下跌4.81%,换手率1.05%,成交量7.49万手,成交额6544.01万元。近5日资金流向一览见下表:复旦张江融资融券信息显示,融资方面,当日融资买入572.4万元,融资偿还524.83万元,融资净买入47.58万元。复旦张江主营业务:主要从事生物医药的创新研究开发、生产制造和市场营销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600014611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01349","BK1191","BK0239","688505"],"gpt_icon":0},{"id":"2483317283","title":"复旦张江11月15日主力资金流出1338万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483317283","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483317283?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:22","pubTimestamp":1731655328,"startTime":"0","endTime":"0","summary":"11月15日, 复旦张江股价跌4.81%,报收8.51元,成交金额6544万元,换手率1.05%,振幅4.81%,量比0.86。复旦张江今日主力资金净流出1338万元,连续3日净流出,上一交易日主力净流出1177万元,今日环比增加13.68%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为41.67%,平均跌幅为2.15%。该股近5个交易日下跌5.65%,主力资金累计净流出2712万元;近20日主力资金累计净流出8091万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115154300a23a3019&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115154300a23a3019&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2483212208","title":"复旦张江(01349):股东杨宗孟拟减持公司股份不超过1036.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483212208","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483212208?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:20","pubTimestamp":1731579634,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(01349)发布公告,公司于近日分别收到杨宗孟、王海波发来的《关于减持复旦张江股份计划的告知函》,因自身资金需求,杨宗孟计划自本公告披露之日起15个交易日后的3个月内通过集中竞价的方式减持公司股份不超过1036.57万股,拟减持比例不超过公司总股本的1%;王海波计划自本公告披露之日起15个交易日后的3个月内通过集中竞价的方式减持公司股份不超过620万股,拟减持比例不超过公司总股本的0.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","BK1191","BK0239","01349"],"gpt_icon":0},{"id":"2483210458","title":"复旦张江(688505.SH):两位主要股东拟减持不超1.6%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483210458","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483210458?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:19","pubTimestamp":1731579566,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(688505.SH)公告,公司持股5%以上股东杨宗孟计划通过集中竞价的方式减持公司股份不超过公司总股本的1%。持股5%以上股东王海波计划通过集中竞价的方式减持公司股份不超过公司总股本的0.60%。据悉,上述两位股东减持价格应不低于8.67元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","688505","01349","BK0239"],"gpt_icon":0},{"id":"2483829547","title":"复旦张江:股东拟减持不超1.6%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483829547","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483829547?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:01","pubTimestamp":1731578470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688505","BK1191","01349","BK0239"],"gpt_icon":0},{"id":"2483810327","title":"复旦张江(01349)下跌5.21%,报2.73元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483810327","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483810327?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:52","pubTimestamp":1731567162,"startTime":"0","endTime":"0","summary":"11月14日,复旦张江(01349)盘中下跌5.21%,截至14:52,报2.73元/股,成交915.58万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。截至2024年三季报,复旦张江营业总收入5.49亿元、净利润8646.86万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14145245284174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688505","01349","BK1191","BK0239"],"gpt_icon":0},{"id":"2483092384","title":"南向资金11月12日净卖出复旦张江165.60万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2483092384","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483092384?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:30","pubTimestamp":1731461412,"startTime":"0","endTime":"0","summary":"11月12日,南向资金减持复旦张江165.60万股连续3日减持。截止当日收盘,港股通共持有复旦张江10162.71万股,占流通股31.16%。复旦张江近5个交易日上涨1.79%,港股通累计减持499.80万股;近20个交易日上涨11.76%,港股通累计减持494.90万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093125a231f0af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093125a231f0af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239","01349"],"gpt_icon":0},{"id":"2481418146","title":"复旦张江11月08日主力资金流出344万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481418146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481418146?lang=zh_cn&edition=full","pubTime":"2024-11-08 15:19","pubTimestamp":1731050359,"startTime":"0","endTime":"0","summary":"11月08日, 复旦张江股价涨0.33%,报收9.02元,成交金额7446万元,换手率1.15%,振幅2.34%,量比1.46。复旦张江今日主力资金净流出344万元,连续3日净流出,上一交易日主力净流出306万元,今日环比增加12.42%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为43.48%,平均跌幅为2.15%。该股近5个交易日上涨5.62%,主力资金累计净流出1044万元;近20日主力资金累计净流出5956万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108153852a2233d41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108153852a2233d41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2481928505","title":"复旦张江(01349)上涨5.02%,报2.93元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481928505","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481928505?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:30","pubTimestamp":1730964613,"startTime":"0","endTime":"0","summary":"11月7日,复旦张江(01349)盘中上涨5.02%,截至15:30,报2.93元/股,成交1763.13万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。截至2024年三季报,复旦张江营业总收入5.49亿元、净利润8646.86万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/07153045030426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","688505","01349","BK0239"],"gpt_icon":0},{"id":"2481928204","title":"复旦张江11月07日遭主力抛售306万元 环比增加4271.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481928204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481928204?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:18","pubTimestamp":1730963902,"startTime":"0","endTime":"0","summary":"11月07日, 复旦张江股价涨1.93%,报收8.99元,成交金额5996万元,换手率0.94%,振幅2.72%,量比1.27。复旦张江今日主力资金净流出306万元,上一交易日主力净流出7万元,今日环比增加4271.43%。该股近5个交易日上涨3.33%,主力资金累计净流出415万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出6797万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152826aba91626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152826aba91626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2479708288","title":"【港股通】复旦张江(01349)奥贝胆酸片上市申请获得药监局受理 拟用于原发性胆汁性胆管炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2479708288","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479708288?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:20","pubTimestamp":1730366412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 复旦张江(01349)公布,公司的附属公司泰州复旦张江药业有限公司(“泰州复旦张江”)收到国家药品监督管理局核准签发的《受理通知书》,奥贝胆酸片(规格:5mg、10mg)用于治疗原发性胆汁性胆管炎(PBC)的药物上市申请获得受理。据悉,该药物属于法尼酯X受体(Farnesoid Xreceptor,“FXR”)激动剂。FXR是一种在肝脏和肠道中高水平表达的核受体,在胆酸代谢调节中起关键性作用。该药物是化学药品3类仿制药,其首个目标适应症为原发性胆汁性胆管炎。","market":"us","thumbnail":"https://static.szfiu.com/news/20200915/NzY4ZGM4YzYyNTA1ODM4NTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NzY4ZGM4YzYyNTA1ODM4NTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YANG","HSTECH","HSCEI","01349","688505","BK1191","BK0239"],"gpt_icon":0},{"id":"2479771323","title":"复旦张江(01349):奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2479771323","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479771323?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:55","pubTimestamp":1730364948,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江 发布公告,该公司的附属公司泰州复旦张江药业有限公司收到国家药品监督管理局核准签发的《受理通知书》,奥贝胆酸片(该药物)用于治疗原发性胆汁性胆管炎的药物上市申请获得受理。该药物是化学药品 3 类仿制药,其首个目标适应症为原发性胆汁性胆管炎。集团对于原研药物的专利限制进行了突破,并在中国大陆获得了相应的专利授权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","01349","688505"],"gpt_icon":0},{"id":"2479710397","title":"复旦张江(01349.HK)奥贝胆酸片治疗胆管炎获受理药物上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2479710397","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479710397?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:53","pubTimestamp":1730364780,"startTime":"0","endTime":"0","summary":"复旦张江(01349.HK) 公布,附属泰州复旦张江收到国家药监局核准签发的《受理通知书》,奥贝胆酸片用于治疗原发性胆汁性胆管炎的药物上市申请获得受理。该药物属于法尼酯X受体激动剂(FXR)。FXR是一种在肝脏和肠道中高水平表达的核受体,在胆酸代谢调节中起关键性作用。该药物是化学药品3类仿制药,其首个目标适应症为原发性胆汁性胆管炎。 (ha/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20181120173426512_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20181120173426512_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1393029/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["688505","01349","BK1191","BK0239"],"gpt_icon":0},{"id":"2479977627","title":"复旦张江(688505.SH):奥贝胆酸片药品上市申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2479977627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479977627?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:40","pubTimestamp":1730364049,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(688505.SH)发布公告,公司全资子公司泰州复旦张江药业有限公司于近日收到国家药品监督管理局下发的关于奥贝胆酸片(规格:5mg、10mg)用于治疗原发性胆汁性胆管炎(PBC)的境内生产药品注册上市许可申请的《受理通知书》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","688505","01349"],"gpt_icon":0},{"id":"2479972089","title":"复旦张江10月31日遭主力抛售514万元 环比增加252.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479972089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479972089?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:18","pubTimestamp":1730359097,"startTime":"0","endTime":"0","summary":"10月31日, 复旦张江股价涨0.23%,报收8.70元,成交金额4342万元,换手率0.70%,振幅2.53%,量比0.79。复旦张江今日主力资金净流出514万元,连续5日净流出,上一交易日主力净流出146万元,今日环比增加252.05%。|10月31日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N强达电路|29.90%|#|风光股份|5.81%|#|立航科技|5.50%|#|赢时胜|4.60%|#|三超新材|4.31%|#|任子行|4.23%|#|星华新材|4.09%|#|王子新材|3.89%|#|中公教育|3.73%|#|大众交通|3.51%|复旦张江所在的化学制药行业,今日主力净流出2.48亿元,行业排名15/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031153457a2000ad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031153457a2000ad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2479623423","title":"复旦张江10月29日主力资金流出1150万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479623423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479623423?lang=zh_cn&edition=full","pubTime":"2024-10-29 15:19","pubTimestamp":1730186363,"startTime":"0","endTime":"0","summary":"10月29日, 复旦张江股价跌4.00%,报收8.65元,成交金额6597万元,换手率1.06%,振幅4.66%,量比1.19。复旦张江今日主力资金净流出1150万元,连续3日净流出,上一交易日主力净流出951万元,今日环比增加20.93%。该股近5个交易日下跌2.81%,主力资金累计净流出3044万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出9508万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154159ab7df730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154159ab7df730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2479448907","title":"复旦张江(01349)下跌5.02%,报2.84元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479448907","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479448907?lang=zh_cn&edition=full","pubTime":"2024-10-29 13:07","pubTimestamp":1730178453,"startTime":"0","endTime":"0","summary":"10月29日,复旦张江(01349)盘中下跌5.02%,截至13:07,报2.84元/股,成交2932.74万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。截至2024年三季报,复旦张江营业总收入5.49亿元、净利润8646.86万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/29130744650500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01349","688505","BK1191","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-19","address":"上海市浦东新区张江高科技园区蔡伦路308号","stockEarnings":[{"period":"1week","weight":-0.0329},{"period":"1month","weight":-0.0753},{"period":"3month","weight":0.2857},{"period":"6month","weight":0.1624},{"period":"1year","weight":-0.2051},{"period":"ytd","weight":-0.0957}],"companyName":"上海复旦张江生物医药股份有限公司","boardCode":"AI0027","perCapita":"35761股","boardName":"医药制造业","registeredCapital":"10365万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究开发、生产制造和市场营销。主要产品为盐酸氨酮戊酸外用散、注射用海姆泊芬、抗肿瘤药物长循环盐酸多柔比星脂质体注射液等。其业务主要包括在中国从事研究、开发及销售自行开发的生物医药知识、为客户提供合约制研究、制造及出售医疗产品,以及提供其他医疗服务。公司还通过其子公司从事医疗投资管理、健康产业管理、项目投资、资产管理、投资咨询、商务咨询、医疗咨询及企业战略咨询业务。","serverTime":1732401764266,"listedPrice":8.95,"stockholders":"19870人(较上一季度增加2.03%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,688505,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}